In part 1 of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the latest on his INGAP research and understanding the role of the brain in diabetes.

In part 2 of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about this year's exciting breakthroughs and reinforcing the importance of reducing cardio events by going beyond the focus on glucose.

In part 3 of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the importance of knowing the resting heart rate and how it impacts the rest of the body.

In part 4 of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the complexity and simplicity of measuring the balance of a patient's autonomic nervous system.

In part 5 of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the best patients to whom to prescribe SGLT-2s or other medication with the use of the correct risk calculator.

In part 6, the conclusion of this Exclusive Interview, Aaron Vinik talks with Diabetes in Control Publisher Steve Freed during the AACE 2018 convention in Boston, MA about the possibility of using available medications to restore the body's balance as well as his thoughts on a possible tool to help with the prescribing of medications.

Associated with increased risk of myocardial infarction, all-cause mortality, severe hypoglycemia

Intermittent energy restriction equivalent to continuous energy restriction for reducing HbA1c

Most announcements of new therapies for diabetes are made by branded drug companies and clinicians, and patients have learned about the “sticker shock” that is associated with these new medications. This week we have a feature that bucks the system, as new research on an old blood pressure medication shows …

Researchers discover safe and effective therapy to reduce insulin requirements and hypoglycemic episodes in adult subjects with recent onset type 1.